Tissue/organ shortage is a major medical challenge due to donor scarcity and patient
immune rejections. Furthermore, it is difficult to predict or mimic the human disease condition …

Implantable drug delivery systems (IDDS) are an attractive alternative to conventional drug
administration routes. Oral and injectable drug administration are the most common routes …

Three-dimensional (3D) printing and 3D bioprinting are promising technologies for a broad
range of healthcare applications from frontier regenerative medicine and tissue engineering …

Type 1 diabetes therapies that afford tighter glycemic control in a more manageable and
painless manner for patients has remained a central focus of next-generation diabetes …

Mitigating the foreign body response (FBR) to implantable medical devices (IMDs) is critical
for successful long‐term clinical deployment. The FBR is an inevitable immunological …

Type 1 diabetes mellitus (T1DM) is a growing global health concern that affects
approximately 8.5 million individuals worldwide. T1DM is characterized by an autoimmune …

Soft tissue reconstructs require materials that form three-dimensional (3-D) structures
supportive to cell proliferation and regenerative processes. Polysaccharides, due to their …

The fast-developing field of 3D bio-printing has been extensively used to improve the
usability and performance of scaffolds filled with cells. Over the last few decades, a variety of …

Novel transplantation techniques are currently under development to preserve the function
of impaired tissues or organs. While current technologies can enhance the survival of …

Type 1 Diabetes Mellitus (T1DM) is characterized by the autoimmune destruction of β-cells
in the pancreatic islets. In this regard, islet transplantation aims for the replacement of the …